59 results
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
direct-acting antivirals ... (DAAs) for chronic ... #DAAs #Antivirals ... #table #treatment ... HepatitisC #Management #Pharmacology
Guide to Treatment of Hepatitis C with Direct Acting Antivirals.

Here is a pocket guide to initial
Direct Acting Antivirals ... of HCV with DAAs ... #Management #Pharmacology ... HepatitisC #HCV #DAA ... #DirectActing #Antivirals
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
study that showed antiviral ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
considerations #pharmacology ... comparison #drugs #treatment ... pharmacotherapy #dermatology
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
Direct-Acting Antivirals ... patients genotype, treatment ... Nomenclature #Classes #DAAs ... #Pharmacology
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... sore throat 10 days ... primarycare #outpatient #treatment ... #pharmacology # ... days
Mild Acne Treatment - Comedones (black/whiteheads), +/- few pustules 
1. Benzoyl Peroxide (BP) 
2. Topical Retinoid
Mild Acne Treatment ... First line pharmacologic ... ambcarerx #Acne #Treatment ... Management #Comedones #Pharmacology ... #Dermatology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... mg/kg every 21 days ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... PO for 90–120 days ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Therapy: 7–14 days ... for effective treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology